Porcine Bocavirus

Overview and Taxonomy of Porcine Bocavirus

Historical Context and Discovery

Porcine bocavirus (PBoV) emerged as a distinct viral entity during a period of intensive investigation into the etiological agents of postweaning multisystemic wasting syndrome (PMWS) in swine. The virus was first identified in 2009 in Sweden through metagenomic analysis of lymph node samples collected from pigs suffering from PMWS, where it was initially described as a "porcine boca-like virus" co-detected alongside porcine circovirus type 2 (PCV2) and torque teno virus (TTV) [6, 16]. This discovery marked the beginning of a concerted global effort to characterize a pathogen that, over the subsequent decade and a half, would be recognized as a ubiquitous and genetically diverse agent with significant implications for swine health, production economics, and potentially public health [2, 6].

The initial identification of PBoV was facilitated by sequence-independent single primer amplification (SISPA), a technique that enabled the detection of novel viral sequences without prior knowledge of the pathogen [29]. This methodological approach proved instrumental in revealing the presence of PBoV in piglet stool samples with a prevalence of 12.59%, leading to the nearly full-length genome characterization of two distinct strains, provisionally designated PBoV1 and PBoV2 [29]. These foundational studies established that PBoV possessed the hallmark genomic architecture of the genus Bocaparvovirus, including the unique NP1 open reading frame (ORF) that distinguishes bocaparvoviruses from other members of the family Parvoviridae [14, 29]. The discovery of PBoV in Sweden was rapidly followed by reports from diverse geographic regions, including China, the United States, Uganda, Kenya, Malaysia, South Africa, and various European nations, underscoring the virus's global distribution and its capacity to circulate within swine populations across continents [2, 8, 11, 19, 22, 26].

Taxonomic Classification and Phylogenetic Framework

PBoV is classified within the genus Bocaparvovirus, subfamily Parvovirinae, family Parvoviridae [2, 4, 16]. The genus Bocaparvovirus encompasses a diverse array of viruses infecting a wide range of vertebrate hosts, including humans (human bocavirus 1–4), canines (canine minute virus), bovines (bovine parvovirus), and rodents (rat bocavirus, rodent bocavirus) [4, 21, 28]. The taxonomic designation "bocavirus" itself is a portmanteau derived from the two earliest recognized members of the genus: bovine parvovirus and canine minute virus [16, 29]. Within the Bocaparvovirus genus, PBoV strains are assigned to multiple species under the International Committee on Taxonomy of Viruses (ICTV) framework. Specifically, PBoV isolates are classified within Ungulate bocaparvovirus 2 (encompassing PBoV1, PBoV2, and PBoV6), Ungulate bocaparvovirus 3 (PBoV5), Ungulate bocaparvovirus 4 (PBoV7), and Ungulate bocaparvovirus 5 (PBoV3, PBoV4-1, and PBoV4-2) [27]. This complex species-level taxonomy reflects the remarkable genetic heterogeneity observed among PBoV strains circulating globally.

Phylogenetic analyses based on the VP1 capsid protein gene have consistently resolved PBoV strains into three major groups, designated Group 1 (G1), Group 2 (G2), and Group 3 (G3) [3, 16, 18]. Group 1 includes the prototype strains PBoV1 and PBoV2, which were the first to be molecularly characterized and share approximately 94.2% nucleotide identity in the NS1 gene [29]. Group 2 encompasses a more heterogeneous collection of strains, while Group 3 has emerged as the most prevalent and genetically diverse cluster, particularly in Chinese swine herds where it has been reported to account for a substantial proportion of circulating PBoV strains [3, 7]. A fourth group, provisionally designated PBoV G4, has been proposed based on sequences obtained from murine rodents and house shrews in China, suggesting that the taxonomic landscape of PBoV may be even more expansive than currently recognized [25]. The classification system based on VP1 sequences has proven to be a robust framework for epidemiological surveillance, enabling researchers to track the emergence and spread of distinct PBoV lineages across geographic regions and over time [9, 18].

Genomic Organization and Structural Features

The PBoV genome consists of linear, single-stranded DNA (ssDNA) approximately 4,700–5,300 nucleotides in length, a size range consistent with other members of the Parvoviridae family [14, 16, 29]. The genome is organized into three primary open reading frames (ORFs) that encode four distinct proteins: the non-structural protein 1 (NS1), the NP1 protein (a non-structural protein unique to bocaparvoviruses), and the two structural capsid proteins VP1 and VP2 [14, 16, 19]. The NS1 protein, encoded by ORF1, is a multifunctional phosphoprotein essential for viral DNA replication, transcriptional regulation, and helicase activity [13, 29]. The NP1 protein, encoded by a mid-genomic ORF, is a defining feature of the genus Bocaparvovirus and has been demonstrated to play a critical role in antagonizing the host type I interferon signaling pathway by targeting the DNA-binding domain of IRF9, thereby inhibiting interferon-stimulated gene expression and facilitating viral immune evasion [13]. The VP1 and VP2 proteins, encoded by ORF2, constitute the viral capsid, with VP1 containing a unique N-terminal region that harbors a secretory phospholipase A2 (sPLA2) motif essential for viral infectivity and endosomal escape during cell entry [29].

Cryo-electron microscopy studies have resolved the capsid structures of PBoV1 at resolutions of 2.3–2.7 Å, revealing conserved parvoviral features such as the channel at the fivefold symmetry axis, which is thought to be involved in genome packaging and release [4]. However, notable structural differences distinguish PBoV1 from other bocaparvoviruses, including canine minute virus and rat bocavirus. Specifically, the threefold protrusions characteristic of many parvoviral capsids are more recessed in PBoV1, and the typical twofold axis depression is either very small or absent [4]. These structural variations likely influence receptor binding, tissue tropism, and antigenic properties, and they underscore the importance of continued structural characterization to inform the development of antiviral strategies and vaccine design [4].

Genetic Diversity and Evolutionary Dynamics

PBoV exhibits extraordinary genetic diversity, a hallmark that has complicated efforts to establish a unified taxonomic framework and has profound implications for viral pathogenesis, immune evasion, and diagnostic assay development. Early studies identified at least seven distinct genotypes based on VP1 sequence analysis, and subsequent investigations have expanded this diversity to encompass numerous variants and recombinant forms [16, 17]. The nucleotide identity among different PBoV strains can be as low as 43.4% for certain genomic regions, while within-group identities typically exceed 90% [7, 17]. This degree of genetic divergence is remarkable for a ssDNA virus and is driven by several evolutionary mechanisms, including high rates of nucleotide substitution, recombination, and host adaptation [5, 14, 28].

Recombination has been identified as a major force shaping PBoV evolution, with evidence of both intra-genotype and inter-genotype recombination events documented across the viral genome [9, 14, 28]. For instance, recombination analysis of Chinese PBoV strains CH/HNZM and PBoV-TY revealed that these viruses likely originated from recombination events involving parental strains from different geographic regions and genetic lineages [9]. Similarly, the PBoV-KU14 strain, which harbors the shortest NP1 gene among all characterized PBoVs, is thought to have arisen through crossover recombination, resulting in a truncated NP1 protein of 600 nucleotides compared to the typical length observed in other strains [14]. The NP1 gene truncation in PBoV-KU14 is particularly noteworthy because NP1 is a key virulence factor involved in interferon antagonism, and alterations in its length or sequence could modulate viral pathogenicity and host range [13, 14].

The genetic diversity of PBoV is further reflected in the phylogenetic incongruence observed among trees constructed using different genomic regions (NS1, NP1, and VP1/VP2), a pattern consistent with a history of recombination and segmental reassortment [14]. This complexity has practical consequences for molecular diagnostics, as assays targeting a single genomic region may fail to detect divergent strains, leading to underestimation of true prevalence [9, 23]. The development of multiplex and pan-genotype detection methods, including SYBR Green-based quantitative PCR assays targeting conserved regions of PBoV1/2 and PBoV3/4/5, as well as MALDI-TOF nucleic acid mass spectrometry platforms, represents a critical advancement in addressing this challenge [9, 20, 23].

Host Range, Tissue Tropism, and Zoonotic Potential

PBoV has been detected in a broad range of host species beyond domestic swine, raising important questions about its evolutionary origins, transmission dynamics, and zoonotic potential. The virus has been identified in murine rodents (Rattus norvegicus, Rattus tanezumi, Rattus losea) and house shrews (Suncus murinus) in China, with prevalence rates of 7.5% in throat swabs, 60.5% in fecal samples, and 22.9% in serum samples [25]. Phylogenetic analysis of sequences obtained from these rodents revealed a distinct cluster, designated PBoV G4, which is genetically distinct from both rodent bocaviruses and human bocaviruses [25]. The high prevalence of PBoV in rodents, particularly in fecal samples, suggests that these animals may serve as reservoirs or mechanical vectors for viral transmission within and between swine herds [21, 25]. Furthermore, ungulate bocaparvovirus 4, a known PBoV species, has been detected in rat liver and serum samples at higher prevalence than rodent bocavirus, and codon usage analysis indicates that these viruses may exhibit greater adaptability to rats than to pigs, supporting the hypothesis that rodents could be the ancestral hosts from which PBoV emerged [21].

The detection of PBoV in Bactrian camels (Camelus bactrianus) in China further expands the known host range and underscores the potential for cross-species transmission events [15]. In a viral metagenomic study of camel intestinal tissues, dromedary camel bocavirus (DBoV1) and porcine astrovirus (PoAstV5) were identified, with DBoV1 showing a prevalence of 36.40% in anal swab samples [15]. Although DBoV1 is genetically distinct from PBoV, its presence in camels highlights the ecological connectivity between swine and other livestock species and the potential for bocaviruses to jump species barriers [15].

Most significantly, PBoV has been documented as a zoonotic agent capable of infecting humans. In 2018, the first confirmed case of human PBoV infection was reported in a 3-year-old child in northeastern Iran who presented with acute upper respiratory tract infection and had a history of close contact with hogs [10]. The child's clinical sample tested positive for PBoV by molecular methods, and no other respiratory pathogens were identified, suggesting that PBoV was the etiological agent of the illness [10]. This finding was corroborated by subsequent reports from Malaysia, where PBoV was detected in a child with respiratory symptoms and a history of exposure to porcine secretions [11]. The zoonotic potential of PBoV is further supported by phylogenetic analyses demonstrating that certain PBoV strains cluster within a clade containing human bocaviruses (HBoVs), indicating close genetic relatedness and a relatively low barrier to cross-species transmission [1]. The World Health Organization (WHO) and the Food and Agriculture Organization (FAO) have emphasized the importance of surveillance for emerging zoonotic pathogens at the human-animal interface, and PBoV exemplifies the type of agent that warrants continued monitoring under a One Health framework [2, 10].

The tissue tropism of PBoV is remarkably broad, encompassing both the respiratory and gastrointestinal tracts, as well as lymphoid tissues, the central nervous system, and potentially other organ systems [1, 5, 7, 12]. Experimental infection studies using the recently isolated PBoV-CNH strain in LLC-PK1 cells demonstrated that orally infected piglets developed acute diarrhea with high intestinal viral loads, while intranasally infected piglets exhibited diarrhea, significant lung pathology, and the highest viral loads in respiratory tissues [1]. This dual respiratory-enteric tropism mirrors the clinical presentation observed in human bocavirus infections and suggests that PBoV can exploit multiple routes of entry and transmission [1, 16]. The detection of PBoV in the central nervous system of a piglet with encephalomyelitis in Germany, confirmed by fluorescent in situ hybridization (FISH) showing intracytoplasmic and intranuclear viral signals within neurons adjacent to inflammatory lesions, indicates that PBoV can also invade the CNS, potentially causing neurological disease [12]. This finding is particularly concerning given that human bocavirus and related parvoviruses (e.g., human parvovirus B19) have been associated with encephalitis in humans [12].

Economic and Agricultural Significance

The economic impact of PBoV on the global swine industry is substantial, though difficult to quantify precisely due to the high frequency of co-infections with other viral and bacterial pathogens [2, 6]. PBoV has been consistently associated with postweaning multisystemic wasting syndrome, respiratory disease, and diarrhea in piglets, conditions that lead to increased mortality, reduced growth rates, higher veterinary costs, and trade restrictions [2, 5, 7, 17]. The World Organisation for Animal Health (WOAH) recognizes the importance of emerging swine pathogens, and the economic burden of PBoV is compounded by its ability to exacerbate the clinical severity of co-infections with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), porcine epidemic diarrhea virus (PEDV), and other enteric pathogens [2, 20, 23, 24]. In China, where PBoV G3 is the most prevalent group, serological surveys using peptide-based ELISAs have revealed seropositivity rates of 47.56% among 1,373 serum samples collected from 12 provinces, indicating widespread exposure and endemic circulation [3]. The high prevalence of PBoV in both healthy and diseased pigs complicates efforts to attribute specific clinical outcomes solely to PBoV infection, but recent experimental fulfillments of Koch's postulates have definitively established PBoV as a primary pathogen capable of causing disease in the absence of other detectable agents [1, 5, 7].

Challenges and Future Directions

Despite

Genomic Organization and Phylogenetic Diversity of Porcine Bocavirus

Porcine bocavirus (PBoV), a member of the genus Bocaparvovirus within the subfamily Parvovirinae of the family Parvoviridae, represents a genetically diverse and globally distributed pathogen of swine [2, 6, 16]. Since its initial discovery in 2009 in Swedish pigs suffering from postweaning multisystemic wasting syndrome (PMWS), the virus has been identified across Asia, Europe, Africa, and North America, revealing a complex genomic architecture and remarkable phylogenetic heterogeneity that continues to expand with ongoing surveillance efforts [1, 5, 6, 8, 19, 22]. Understanding the genomic organization and evolutionary relationships of PBoV is fundamental to elucidating its pathogenic mechanisms, host range, and potential for cross-species transmission, particularly given its demonstrated zoonotic capacity [1, 10-12].

2.1. The Bocaparvovirus Genome: A Tripartite Architecture

The PBoV genome is a linear, single-stranded DNA molecule of approximately 4,700 to 5,300 nucleotides in length, a size range consistent with other members of the Parvoviridae family [4, 14, 16, 18, 29]. The defining genomic feature that distinguishes bocaparvoviruses from other parvoviruses is the presence of three major open reading frames (ORFs), encoding four primary proteins: the non-structural protein 1 (NS1), the nucleoprotein 1 (NP1), and the structural proteins VP1 and VP2, with VP2 being entirely contained within the VP1 coding sequence [2, 16, 19, 29]. This tripartite organization, NS1, NP1, and VP1/VP2, is a hallmark of the genus Bocaparvovirus and is shared with human bocaviruses (HBoVs), bovine parvovirus (BPV), and minute virus of canines (MVC) [4, 28, 29]. The NS1 protein, encoded by the 5′ ORF, is a multifunctional non-structural protein essential for viral DNA replication, transcriptional regulation, and helicase activity [16, 19]. The NP1 protein, encoded by a central ORF unique to bocaparvoviruses, is a non-structural protein of approximately 200–220 amino acids with critical roles in evading the host innate immune response [13, 14, 29]. The VP1 and VP2 proteins, encoded by the 3′ ORF, constitute the viral capsid, with VP1 containing a unique N-terminal region that harbors a secretory phospholipase A2 (sPLA2) motif essential for viral infectivity and endosomal escape [4, 18, 29].

The genomic termini of PBoV contain palindromic sequences that form hairpin structures, which are critical for priming viral DNA replication via a rolling-hairpin mechanism, a conserved feature among parvoviruses [4]. High-resolution cryo-electron microscopy (cryo-EM) structures of the PBoV1 capsid, resolved to 2.3–2.7 Å, have revealed a T=1 icosahedral lattice with conserved features at the fivefold symmetry axis, including a channel hypothesized to be involved in genome packaging and externalization of the VP1 N-terminal sPLA2 domain [4]. However, significant structural divergence from other bocaparvoviruses is observed at the two- and threefold axes. Unlike the prominent threefold protrusions characteristic of canine minute virus (CnMV), the PBoV1 capsid exhibits more recessed threefold regions, and the typical twofold depression is either very small or absent [4]. These structural variations likely influence receptor binding, tissue tropism, and antigenic diversity, underscoring the importance of capsid architecture in PBoV biology.

2.2. Genomic Variability and the NP1 Gene

A remarkable feature of PBoV genomic diversity is the variability observed in the NP1 gene. While the NP1 protein is a conserved hallmark of the genus, its length and sequence can vary significantly among PBoV strains. For instance, the strain PBoV-KU14, identified in South Korea, harbors the shortest NP1 gene among all characterized PBoVs, with a length of only 600 nucleotides, compared to the more typical 612–630 nucleotides found in other strains [14]. This truncation, which results in a premature stop codon, is hypothesized to arise from crossover recombination events, a common driver of genetic diversity in parvoviruses [14]. The functional consequences of NP1 truncation are not fully understood, but given the protein’s established role in antagonizing the type I interferon (IFN) signaling pathway, such variations could significantly impact viral virulence and host immune evasion [13]. Mechanistic studies have demonstrated that PBoV NP1 suppresses IFN-stimulated response element (ISRE) activity and subsequent IFN-stimulated gene (ISG) expression by directly binding to the DNA-binding domain (DBD) of interferon regulatory factor 9 (IRF9) [13]. This interaction blocks the DNA-binding activity of the heterotrimeric transcription factor complex ISGF3 (STAT1/STAT2/IRF9), thereby attenuating the host’s innate antiviral response [13]. The presence of NP1 variants with altered lengths or sequences could modulate the efficiency of this immune evasion strategy, potentially influencing the outcome of infection.

Further genomic complexity is introduced by the presence of an additional ORF (ORF3) in some bocaparvoviruses, a feature that was initially described in bovine parvovirus 2 (BPV2) and later identified in porcine parvovirus 4 (PPV4) [32, 33]. However, PPV4 is not classified within the genus Bocaparvovirus but rather within the genus Copiparvovirus, and its ORF3-encoded protein shares minimal sequence identity with the NP1 protein of true bocaviruses [31-33]. This distinction is critical for accurate taxonomic classification and highlights the convergent evolution of genomic features across different parvovirus genera.

2.3. Phylogenetic Classification and the Emergence of Multiple Genogroups

Phylogenetic analyses based on complete genome sequences and individual gene segments (NS1, NP1, VP1/VP2) have consistently revealed that PBoV strains form a highly diverse group, currently classified into multiple genogroups or species within the genus Bocaparvovirus [2, 16-18, 29]. The International Committee on Taxonomy of Viruses (ICTV) recognizes several species of ungulate bocaparvoviruses that infect swine, including Ungulate bocaparvovirus 2 (encompassing PBoV1, PBoV2, and PBoV6), Ungulate bocaparvovirus 3 (PBoV5), Ungulate bocaparvovirus 4 (PBoV7), and Ungulate bocaparvovirus 5 (PBoV3, PBoV4-1, and PBoV4-2) [21, 27]. This taxonomic framework, however, is continuously evolving as new strains are discovered.

A widely adopted classification scheme, based on the VP1 gene sequence, divides PBoV strains into three major groups: group 1 (G1), group 2 (G2), and group 3 (G3) [3, 16, 18]. Group 3, which includes PBoV3, PBoV4, and PBoV5, is further subdivided into subgroups such as G3A, G3B, and G3C [11, 18]. Epidemiological studies have demonstrated that PBoV G3 is the most prevalent genogroup in China, with serological surveys using a VP1 peptide-based ELISA detecting antibodies in 47.56% of 1,373 serum samples collected from 12 provinces [3]. The genetic distance between these groups is substantial; for example, the NS1 protein sequence identity between different PBoV species can be as low as 28–43%, while strains within the same species share 98–99% identity [19]. This level of divergence is comparable to that observed between different species of human bocaviruses and underscores the extensive evolutionary radiation of PBoV.

Phylogenetic incongruence, where phylogenetic trees constructed from different gene segments (e.g., NS1 vs. VP1) yield conflicting topologies, is a common observation in PBoV studies and is a strong indicator of recombination [14, 18, 28]. For instance, the strain PBoV-KU14, which clusters with Ungulate bocaparvovirus 4 based on NS1 and VP1/VP2 sequences, shows a different phylogenetic placement when the NP1 gene is analyzed, suggesting a recombinant origin [14]. Similarly, recombination analysis of Chinese PBoV strains CH/HNZM and PBoV-TY revealed that they likely originated from recombination events involving the strains GD18, 0912/2012, and 57AT-HU [9]. These recombination events, which can occur both within and between genogroups, are a major driving force of PBoV evolution, generating novel genetic combinations that may confer selective advantages, such as altered tissue tropism, immune evasion, or expanded host range [28].

2.4. Global Phylogenetic Diversity and the Discovery of Novel Groups

The geographic distribution of PBoV genogroups is complex, with different groups predominating in different regions and often co-circulating within the same herd [9, 17, 26]. Early studies in China identified six distinct groups (PBoV-a to PBoV-f) based on partial NS1 sequences from slaughter pigs, with nucleotide identities ranging from 90.1% to 99% [17]. Subsequent metagenomic and PCR-based surveys have continued to uncover novel genetic lineages. A landmark study using viral metagenomics on fecal samples from piglets in China identified a novel group, provisionally named PBoV3C, which exhibited only 78–81% genomic sequence identity to previously known PBoV3A/B and PBoV3D/E strains [18]. This finding highlighted the high diversity and prevalence of PBoV in apparently healthy animals and led to the proposal of a uniform nomenclature system based on the VP1 gene [18].

The discovery of PBoV in non-porcine hosts has further expanded the phylogenetic landscape. In China, a novel group designated PBoV G4 was identified in murine rodents (Rattus norvegicus, Rattus tanezumi, Rattus losea) and house shrews (Suncus murinus), with a high prevalence of 60.5% in fecal samples [25]. Phylogenetic analysis of the VP1/VP2 region clearly separated PBoV G4 from all previously known PBoV groups and from rodent, human, and other bocaviruses, indicating that this group represents a distinct lineage that may have originated in rodents and subsequently spilled over into swine [25]. This hypothesis is supported by a comprehensive study comparing ungulate bocaparvovirus 4 and rodent bocavirus, which found that these viruses share over 84% nucleotide identity in the NS1 region, have similar genomic structures and codon usage bias, and exhibit greater adaptability to rats than to pigs [21]. The authors proposed that ungulate bocaparvovirus 4 and rodent bocavirus may be different genotypes of the same bocavirus species and that rats may serve as a natural reservoir [21]. The detection of PBoV in mink feces in China further underscores the potential for cross-species transmission and the existence of unsampled viral diversity in wildlife [30].

2.5. Phylogenetic Relationships with Human Bocaviruses and Zoonotic Implications

One of the most significant findings from phylogenetic studies of PBoV is its close genetic relationship with human bocaviruses (HBoVs). The successful isolation and propagation of the PBoV-CNH strain in LLC-PK1 cells revealed that this strain shares 94.15% whole-genome nucleotide identity with the NCBI reference strain and clusters within a clade containing HBoVs, highlighting a close evolutionary proximity [1]. This phylogenetic relatedness, combined with the experimental demonstration of dual respiratory-enteric tropism in piglets and the documented case of a human child with acute respiratory tract infection caused by PBoV in Iran, signals a tangible risk of cross-species transmission [1, 10]. The Iranian case, involving a 3-year-old child in close contact with hogs, represents the first confirmed human infection with PBoV and underscores the zoonotic potential of this virus [10, 11]. Furthermore, the detection of PBoV in the central nervous system (CNS) of a pig with encephalomyelitis in Germany, coupled with the known ability of human bocavirus to cause encephalitis, raises concerns about the potential for PBoV to cause neurological disease in humans [12]. The phylogenetic proximity between PBoV and HBoV, particularly in the VP1 gene, suggests that these viruses share a common ancestor and that host-switching events may have occurred in the past [1, 28]. This evolutionary relationship necessitates continued surveillance of PBoV diversity in swine populations, particularly in regions with high human-pig contact, to monitor for the emergence of strains with enhanced zoonotic potential. The World Health Organization (WHO) and the Food and Agriculture Organization (FAO) have emphasized the importance of a One Health approach to monitor emerging zoonotic pathogens at the human-animal interface, and PBoV represents a compelling candidate for such surveillance efforts.

In Vitro Propagation and Cell Culture Systems for Porcine Bocavirus

The establishment of robust in vitro propagation systems for porcine bocavirus (PBoV) has historically represented one of the most formidable barriers to advancing our understanding of this pathogen’s fundamental virology, pathogenesis, and immunobiology. For over a decade following its initial discovery in Swedish pigs with postweaning multisystemic wasting syndrome (PMWS) in 2009 [6, 16], the field was severely constrained by the complete absence of a permissive continuous cell line capable of supporting efficient viral replication. This limitation not only precluded the fulfillment of Koch’s postulates but also hindered the development of critical research tools, including neutralization assays, antiviral screening platforms, and vaccine candidate evaluation systems. The recent breakthroughs in PBoV cell culture isolation, particularly the successful propagation of strains in LLC-PK1 cells, have fundamentally transformed the research landscape and opened new avenues for investigating this emerging swine pathogen [1, 7].

Historical Challenges and the Search for Permissive Cell Systems

The protracted inability to propagate PBoV in vitro stemmed from several intrinsic biological characteristics of the virus and the lack of optimized culture conditions. As a member of the genus Bocaparvovirus within the family Parvoviridae, PBoV possesses a linear single-stranded DNA genome of approximately 5.0–5.2 kb, encoding four major proteins: the non-structural protein NS1, the unique bocavirus NP1 protein, and the structural proteins VP1 and VP2 [16, 29]. Unlike many other parvoviruses that replicate efficiently in dividing cells due to their dependence on host cell DNA polymerase machinery and S-phase cellular factors, bocaviruses have demonstrated fastidious growth requirements that have historically complicated their isolation. Early attempts to propagate PBoV using a variety of conventional swine cell lines, including PK-15, ST (swine testicle), and primary porcine kidney cells, consistently yielded negative results, leading to the prevailing assumption that PBoV might require specific host factors present only in particular cell types or differentiation states [6, 16].

The situation was further complicated by the extensive genetic diversity among PBoV strains, which have been classified into three major groups (G1, G2, and G3) based on VP1 gene sequences, with multiple genotypes within each group [9, 14, 18]. This genetic heterogeneity raised the possibility that different PBoV groups might exhibit distinct cell tropism and growth requirements, potentially explaining why some strains could be detected by molecular methods in clinical samples but could not be cultured. The discovery of PBoV in diverse tissues, including intestinal contents, respiratory tract, lymph nodes, tonsils, serum, and even central nervous system tissue, suggested a broad tissue tropism in vivo that might not be faithfully recapitulated in standard monolayer cultures derived from a single tissue type [12, 17].

Breakthrough Isolation in LLC-PK1 Cells: The PBoV-CNH Strain

The seminal breakthrough in PBoV cell culture came with the report by Ji et al. (2025) describing the successful isolation and serial propagation of a novel PBoV strain, designated PBoV-CNH, in LLC-PK1 cells [1]. LLC-PK1 is a continuous cell line derived from the kidney of a 3–4-week-old pig, an age that corresponds precisely to the period of peak susceptibility to PBoV infection in the natural host. This age-matched cell line selection proved to be a critical factor in achieving successful isolation, as it likely provided the specific cellular factors, receptor expression profiles, and intracellular environment necessary for efficient viral entry, genome replication, and progeny virion assembly.

The PBoV-CNH isolate was obtained from diarrheic piglets in China and exhibited all the characteristic features of a typical bocavirus. Transmission electron microscopy revealed non-enveloped, icosahedral particles measuring 20–30 nm in diameter, consistent with the morphology of other parvoviruses [1]. Whole-genome sequencing demonstrated that PBoV-CNH shared 94.15% nucleotide identity with the NCBI reference strain (NC_016031.1), confirming its classification within the Bocaparvovirus genus. Importantly, the isolate displayed hemagglutination activity (HA), a property characteristic of many members of the Parvoviridae family that has been exploited for diagnostic and virological studies [1].

The successful propagation of PBoV-CNH in LLC-PK1 cells was not merely a technical achievement but provided definitive evidence that PBoV could function as a primary pathogen. Experimental infection of piglets via oral and intranasal routes fulfilled Koch’s postulates, demonstrating that the cell culture-derived virus could recapitulate the full spectrum of clinical disease, including acute diarrhea, respiratory distress, and significant lung pathology [1]. The dual respiratory-enteric tropism observed in these experiments, with orally infected piglets developing high intestinal viral loads and intranasally infected animals showing the highest viral titers in respiratory tissues, validated the relevance of the LLC-PK1 culture system for studying PBoV pathogenesis.

Trypsin-Dependent Propagation and the BK19 Strain

Concurrent with the work on PBoV-CNH, Hu et al. (2026) reported the isolation of another Chinese PBoV strain, designated BK19, using a modified approach that incorporated trypsin supplementation into the LLC-PK1 culture system [7]. The BK19 strain was isolated from diarrheic piglets in Hunan Province, and its successful propagation required the addition of trypsin to the culture medium, a strategy commonly employed for the isolation of enteric viruses that require proteolytic cleavage of viral surface proteins for efficient cell entry and spread.

The trypsin-dependent nature of BK19 propagation provides important insights into the molecular mechanisms of PBoV entry and tropism. Many enteric viruses, including rotaviruses and influenza viruses, depend on host proteases for the cleavage of viral attachment proteins, which is essential for membrane fusion and viral uncoating. The requirement for exogenous trypsin suggests that PBoV may possess a similar dependence on proteolytic activation, potentially explaining why earlier attempts at isolation in the absence of trypsin were unsuccessful. This finding has significant implications for the design of future isolation protocols and suggests that trypsin supplementation should be considered a standard component of PBoV cell culture media.

The BK19 isolate was thoroughly characterized using multiple complementary techniques, including immunofluorescence assay (IFA), electron microscopy, plaque formation, and growth kinetics analysis [7]. Whole-genome sequencing revealed that BK19 exhibited 43.4–95.7% nucleotide identity with known PBoV strains, with phylogenetic analysis placing it within the G3 genogroup, the most prevalent PBoV group in Chinese swine herds [3, 7]. The ability to form visible plaques in LLC-PK1 monolayers represents a particularly valuable feature of this culture system, as plaque assays are essential for virus quantification, purification of clonal viral populations, and the performance of neutralization assays.

Age-Dependent Pathogenicity and Cell Culture Correlates

The availability of cell culture-propagated PBoV strains has enabled detailed investigations into the age-dependent pathogenicity of this virus, a phenomenon that was previously impossible to study systematically. Hu et al. (2026) conducted experimental infections in piglets of three distinct age groups, 5–8 days old, 17–19 days old, and 31–33 days old, using the BK19 strain propagated in LLC-PK1 cells [7]. The results demonstrated a clear age-dependent gradient of susceptibility, with the youngest piglets (5–8 days old) developing the most severe clinical signs, including fever, respiratory distress, and diarrhea lasting 3–4 days. Viral shedding in rectal swabs peaked at 4 days post-infection (dpi) in all groups, but the duration of shedding was prolonged in the younger animals, with persistent detection through 14 dpi.

Postmortem examination revealed broad tissue tropism in the 5–8 and 17–19-day-old piglets, with viral antigen detected by immunohistochemistry in intestinal, pulmonary, lymphoid, and renal tissues [7]. The correlation between enhanced viral replication in cell culture and increased pathogenicity in young animals suggests that the LLC-PK1 system faithfully recapitulates the biological properties of PBoV in vivo. This age-dependent susceptibility mirrors the epidemiological pattern observed in field studies, where PBoV is most frequently detected in weaning piglets and young animals [6, 17].

Optimization of Culture Conditions and Viral Growth Kinetics

The successful establishment of PBoV cell culture systems has allowed for the systematic optimization of growth conditions and the characterization of viral replication kinetics. Studies using the BK19 strain in LLC-PK1 cells have demonstrated that optimal viral yields are achieved when cells are maintained in medium supplemented with trypsin at concentrations ranging from 2–5 μg/mL, with virus adsorption periods of 60–90 minutes at 37°C [7]. The growth kinetics of PBoV in this system follow a pattern typical of parvoviruses, with an eclipse phase of approximately 12–18 hours post-infection, followed by exponential viral production that peaks at 48–72 hours post-infection.

The development of plaque assays has enabled precise quantification of infectious viral titers, with the BK19 strain producing clear, well-defined plaques of approximately 1–2 mm in diameter after 5–7 days of incubation under agarose overlay [7]. The ability to perform plaque purification is particularly important for generating clonal viral stocks for genetic studies and for the selection of attenuated vaccine candidates. Furthermore, the establishment of growth curves and the determination of multiplicity of infection (MOI) parameters provide essential tools for standardized experimental protocols.

Implications for Vaccine Development and Antiviral Screening

The availability of cell culture systems for PBoV propagation has profound implications for the development of control strategies against this emerging pathogen. Prior to these breakthroughs, the absence of a permissive cell line precluded the production of inactivated or live-attenuated vaccines, which remain the most effective tools for controlling viral diseases in swine populations. The ability to propagate PBoV to high titers in LLC-PK1 cells, a cell line that is already approved for vaccine production in many regulatory jurisdictions, provides a clear pathway for vaccine development.

The cell culture system also enables high-throughput screening of antiviral compounds, which is particularly important given the absence of specific antiviral therapies for PBoV infection. The plaque reduction neutralization test (PRNT) can now be employed to evaluate the efficacy of potential antiviral agents, including nucleoside analogs, protease inhibitors, and compounds targeting viral replication or assembly. Additionally, the system facilitates the production of viral antigens for serological assays, such as the VP1 peptide-based ELISA recently developed for detecting PBoV G3 antibodies [3].

Cross-Species Transmission and Public Health Considerations

The successful propagation of PBoV in cell culture has taken on added significance in light of growing evidence for the zoonotic potential of this virus. The phylogenetic proximity of PBoV to human bocaviruses (HBoVs), combined with the documented case of PBoV infection in a 3-year-old child with acute respiratory tract infection in Iran [10], has raised concerns about the risk of cross-species transmission. The LLC-PK1 culture system provides a valuable platform for studying the molecular determinants of host range and tropism that may govern interspecies transmission.

The World Health Organization (WHO) and the World Organisation for Animal Health (WOAH) have emphasized the importance of a One Health approach to emerging infectious diseases, recognizing that approximately 60% of human infectious diseases originate from animals. The ability to propagate PBoV in cell culture enables detailed studies of viral receptor usage, host factor requirements, and the genetic basis of host range restriction. Such studies are essential for assessing the pandemic potential of PBoV and for developing surveillance strategies to monitor for spillover events.

Future Directions and Unresolved Challenges

Despite these remarkable advances, several challenges remain in the optimization and standardization of PBoV cell culture systems. The current dependence on LLC-PK1 cells, while successful for the isolation of G3 strains, may not be equally permissive for all PBoV genotypes. The extensive genetic diversity among PBoV strains, with at least seven genotypes classified into three major groups [16, 17], raises the possibility that different lineages may require distinct cell types or culture conditions for efficient propagation. Systematic screening of additional porcine cell lines, including those derived from respiratory epithelium (e.g., primary porcine airway epithelial cells), intestinal epithelium (e.g., IPEC-J2 cells), and lymphoid tissues, may be necessary to establish a comprehensive panel of permissive cell lines.

The development of reverse genetics systems for PBoV represents another critical priority. Infectious clone technology, which has been successfully established for many other parvoviruses, would enable the precise manipulation of the viral genome to study the functions of individual proteins, identify virulence determinants, and engineer attenuated vaccine strains. The availability of cell culture systems that support high-titer viral replication is a prerequisite for the rescue of recombinant viruses from cloned DNA.

Furthermore, the establishment of three-dimensional cell culture models, such as organoids derived from porcine intestinal or respiratory tissues, could provide more physiologically relevant systems for studying PBoV pathogenesis and host-virus interactions. These advanced culture systems better recapitulate the architecture and cellular diversity of native tissues and may reveal aspects of viral tropism and pathogenesis that are not apparent in conventional monolayer cultures.

In conclusion, the successful in vitro propagation of PBoV in LLC-PK1 cells represents a watershed moment in the study of this emerging swine pathogen. The availability of cell culture systems has transformed PBoV research from a largely descriptive, molecular detection-based discipline into an experimentally tractable field capable of addressing fundamental questions about viral biology, pathogenesis, and host interactions. The continued refinement and expansion of these culture systems will be essential for developing effective vaccines, antiviral therapies, and diagnostic tools to mitigate the impact of PBoV on swine health and to assess the potential risks to public health.

Molecular Pathogenesis and Dual Respiratory-Enteric Tropism of Porcine Bocavirus

The elucidation of porcine bocavirus (PBoV) pathogenesis has historically been hampered by the absence of a robust in vitro propagation system, a critical barrier that persisted for over a decade since its initial discovery in 2009 [1, 6]. This limitation precluded classical virological approaches, such as plaque purification, growth curve analysis, and controlled mutagenesis, which are essential for dissecting molecular determinants of virulence. However, recent landmark achievements in isolating and serially passaging PBoV in continuous cell lines, specifically LLC-PK1 cells, a porcine kidney epithelial cell line, have fundamentally transformed our understanding of its biology [1, 7]. These breakthroughs, coupled with experimental infection models that fulfill Koch’s postulates, have provided the first definitive evidence that PBoV is not merely a commensal or opportunistic agent but a primary pathogen capable of inducing clinical disease in swine [1, 5, 7]. The pathogenesis of PBoV is characterized by a remarkable and clinically significant dual tropism for both the respiratory and gastrointestinal tracts, a feature that distinguishes it from many other porcine parvoviruses and underpins its complex disease presentation and transmission dynamics.

Capsid Architecture and Cellular Tropism Determinants

The molecular basis for PBoV’s dual tropism is rooted in the structural biology of its capsid. High-resolution cryo-electron microscopy (cryo-EM) structures of the PBoV1 capsid, resolved at 2.3–2.7 Å, have revealed a unique surface topology that diverges significantly from other parvoviruses, particularly at the two- and threefold axes of symmetry [4]. Unlike canine minute virus (CnMV), which possesses prominent threefold protrusions, the corresponding region in PBoV1 is markedly recessed, and the typical twofold depression characteristic of many parvoviruses is either very small or absent in both PBoV and rat bocavirus [4]. This distinctive surface architecture is predicted to influence receptor recognition and binding. The capsid must engage with distinct cellular receptors or attachment factors on the apical surfaces of intestinal enterocytes and respiratory epithelial cells. While the specific receptor(s) for PBoV remain unidentified, it is hypothesized that the capsid proteins (VP1 and VP2) interact with sialic acid moieties or other glycoconjugates, a common strategy among parvoviruses, as evidenced by the hemagglutination activity (HA) exhibited by the PBoV-CNH isolate [1]. The ability of a single viral capsid to mediate entry into two distinct cell types suggests the utilization of a broadly expressed, ubiquitous receptor or the possession of multiple, tissue-specific attachment domains within the VP1/VP2 proteins.

The Phospholipase A2 (PLA2) Domain and Endosomal Escape

Following receptor-mediated endocytosis, the viral genome must be delivered to the nucleus for replication. A critical step in this process is the endosomal escape of the virus particle, which is mediated by a secreted phospholipase A2 (sPLA2) motif located within the unique region of the VP1 protein (VP1u) [29, 34]. This domain is highly conserved across the Parvoviridae family and is essential for viral infectivity. In PBoV, the sPLA2 motif contains a conserved catalytic center (HDXXY) and a Ca²⁺-binding loop (YXGXF), the latter of which differs from the YXGXG motif found in most other parvoviruses but is shared with human bocaviruses (HBoVs) [29]. This enzymatic activity is crucial for breaching the endosomal membrane, allowing the viral particle to translocate into the cytoplasm. The efficiency and pH-dependence of this PLA2 activity could contribute to tissue tropism, as differences in endosomal maturation pathways and lipid compositions between respiratory and enteric epithelial cells may affect the kinetics of membrane disruption. This is particularly relevant given that the experimental strains PBoV-CNH and BK19 were both isolated and propagated in trypsin-supplemented LLC-PK1 cells, suggesting that proteolytic cleavage of capsid proteins by trypsin-like proteases, abundant in the intestinal lumen, may be a prerequisite for efficient PLA2 activation and subsequent infection of enteric tissues [1, 7].

NP1-Mediated Immune Evasion: A Master Regulator of Pathogenesis

A defining characteristic of the Bocaparvovirus genus is the presence of an additional open reading frame encoding the NP1 protein, whose function is pivotal to viral pathogenesis [13, 14, 29]. PBoV NP1 has been identified as a potent antagonist of the host type I interferon (IFN) signaling pathway, a critical antiviral defense system. Mechanistically, PBoV NP1 specifically targets the DNA-binding domain (DBD) of interferon regulatory factor 9 (IRF9), a component of the heterotrimeric interferon-stimulated gene factor 3 (ISGF3) complex [13]. ISGF3, comprising STAT1, STAT2, and IRF9, translocates to the nucleus upon IFN stimulation and binds to interferon-stimulated response elements (ISREs) to activate the transcription of hundreds of interferon-stimulated genes (ISGs) that establish an antiviral state.

Remarkably, PBoV NP1 does not interfere with the upstream activation or nuclear translocation of STAT1 and STAT2, nor does it prevent the formation of the ISGF3 complex itself [13]. Instead, by binding directly to the DBD of IRF9, NP1 physically obstructs the ability of the assembled ISGF3 complex to bind to its cognate DNA target sequences, thereby silencing the expression of ISGs. This precise and elegant mechanism of immune subversion suppresses the innate antiviral response, creating a permissive environment for viral replication. This immune evasion strategy is likely a key factor enabling the establishment of a productive and disseminated infection in both the respiratory and enteric tracts. The widespread detection of PBoV in lymphoid tissues, such as lymph nodes and tonsils [17, 22], suggests that NP1's antagonism of IFN signaling in immune cells may also facilitate systemic spread and immunopathogenesis. The NP1 gene itself exhibits significant genetic variability, with strains like PBoV-KU14 harboring a truncated NP1 gene [14], and the stop codon location differing between strains, as seen in the encephalomyelitis-associated PBoV S1142/13 [12]. This variability suggests that the efficacy of IFN antagonism may vary between circulating genotypes, potentially influencing their pathogenic potential and tissue tropism.

In Vivo Evidence for Dual Respiratory-Enteric Tropism

The most compelling evidence for the intrinsic dual tropism of PBoV comes from controlled experimental infection studies using both the PBoV-CNH and BK19 isolates. In these studies, the route of inoculation was a critical determinant of clinical outcome and the primary site of viral replication [1, 7]. Orally infected piglets developed acute diarrhea with high viral loads confined predominantly to intestinal tissues, confirming a classical enteric tropism and fulfilling the viral component of enteric disease causation [1, 5]. In stark contrast, intranasally infected piglets developed not only profound respiratory pathology, including gross and microscopic lung lesions, but also exhibited significant diarrhea with high concurrent viral loads in both respiratory (lung, trachea) and enteric (intestinal mucosa, feces) tissues [1]. This finding demonstrates that PBoV introduced via the respiratory route can quickly establish a secondary infection in the gastrointestinal tract, a hallmark of a pathogen with dual, independent tropisms rather than a strict enteric virus that rarely invades other systems.

Furthermore, the age-dependent pathogenicity is a critical facet of PBoV pathogenesis. Experimental infections in piglets of different ages (5–8, 17–19, and 31–33 days old) revealed that the youngest piglets were significantly more susceptible, exhibiting more severe clinical signs including fever, respiratory distress, and diarrhea, along with higher viral loads and broader tissue distribution [7]. Immunohistochemical analysis of these tissues confirmed the presence of PBoV antigen in intestinal crypt epithelial cells, pulmonary alveolar cells, and importantly, in lymphoid tissues and renal tubular epithelium, illustrating a pantropic capacity that extends beyond the respiratory and enteric tracts [7]. The detection of PBoV in the central nervous system (CNS) of a piglet with encephalomyelitis, with viral RNA localized within neurons adjacent to inflammatory lesions by in situ hybridization, further extends the viral tropism and pathogenic potential, suggesting the virus can, in some cases, breach the blood-brain barrier [12]. This neurotropic capability, while seemingly rare, is a significant concern and mirrors findings with human bocavirus in encephalitis patients.

Evolutionary Drivers and Implications for Cross-Species Transmission

The dual tissue tropism of PBoV may be an evolutionary consequence of high recombination rates and subsequent host adaptation. Phylogenetic incongruence between the NS1, NP1, and VP1/VP2 genes of various PBoV strains strongly suggests that inter- and intra-genotype recombination is a frequent and powerful driver of genetic diversity, allowing for the shuffling of tropism-associated genes [9, 14, 28]. The phospholipase A2 (PLA2) site and the capsid structure, both critical for cell entry, are prime targets for such recombination, potentially allowing the virus to rapidly adapt to new tissue environments [4, 29].

This genetic plasticity has profound public health implications. The close phylogenetic relationship between PBoV and human bocaviruses, particularly the clustering of the PBoV-CNH strain within a clade containing HBoVs [1], along with the first documented case of human PBoV infection in a child presenting with acute respiratory illness [10], signals a tangible and concerning risk of zoonotic spillover. The dual tropism of PBoV facilitates its shedding from both the respiratory tract (via coughing and sneezing) and the gastrointestinal tract (via feces), creating multiple pathways for environmental contamination and exposure to humans in close contact with swine, such as farmers and veterinarians. The detection of PBoV in rodents, such as Rattus norvegicus and house shrews (Suncus murinus), with the discovery of a novel PBoV G4 group, indicates that the virus has the capacity to jump species barriers and establish itself in novel reservoir hosts [25]. Furthermore, the finding that ungulate bocaparvovirus 4 and rodent bocavirus may be different genotypes of the same species originating from rats [21] suggests that rodents could act as a bridging host, facilitating the transmission of PBoV from swine to other mammalian species, including humans. This complex ecological and molecular interplay underscores the necessity for comprehensive "One Health" surveillance, integrating virological monitoring in swine populations, rodent control programs, and vigilance for respiratory and enteric illnesses of unknown etiology in individuals with occupational or environmental exposure to pigs. The World Organization for Animal Health (WOAH) and the FAO recognize the economic and zoonotic potential of emerging swine pathogens, and the documented human case of PBoV places it firmly under this surveillance umbrella.

Epidemiology, Transmission Dynamics, and Economic Impact of Porcine Bocavirus

The epidemiology of porcine bocavirus (PBoV) presents a complex and still-emerging picture, characterized by global ubiquity, high within-herd prevalence, extensive genetic diversity, and a multifaceted transmission ecology that extends beyond domestic swine into rodents and potentially humans. Understanding these dimensions is not merely an academic exercise; it is foundational for designing effective surveillance, control, and biosecurity strategies. Moreover, the economic ramifications of PBoV infection, while difficult to disentangle from concurrent infections, are increasingly recognized as substantial, impacting everything from production efficiency to international trade.

Global Prevalence and Geographic Distribution

Since its initial discovery in Swedish pigs with postweaning multisystemic wasting syndrome (PMWS) in 2009 [6, 16], PBoV has been documented across the globe, confirming its status as a cosmopolitan pathogen. Initial reports emerged from Asia, with detection in China [17, 18, 29], South Korea [14], and Malaysia [11]. In China alone, large-scale serological surveys using recently developed tools have revealed staggering seroprevalence rates; an indirect ELISA based on a VP1 peptide from the highly prevalent Group 3 (G3) viruses detected antibodies in 47.56% of 1,373 serum samples collected across 12 provinces between 2022 and 2023 [3]. Molecular detection rates from clinical samples in central China have reached 52.67% for PBoV1/2 and 41.63% for PBoV3/4/5, with over 86% of surveyed farms testing positive [9]. These figures underscore that PBoV is not a rare or sporadic agent but an endemic fixture in many swine-dense regions.

The virus’s reach extends across Europe. Studies from Ireland detected PBoV in archived faecal samples from asymptomatic piglets, with phylogenetic analysis revealing three distinct circulating groups and a statistically significant correlation between PBoV and porcine adenovirus co-infections [26]. In Germany, a landmark case identified PBoV in the central nervous system of a piglet with encephalomyelitis, demonstrating an unexpected neurotropic potential [12]. African data, though more limited, are equally telling. The first complete genome sequences from East Africa, originating from Uganda and Kenya, confirmed the presence of PBoV on the continent, with high amino acid identity (98-99%) to Chinese and Swedish strains within the same species, suggesting a global dissemination pattern [8, 19]. Even in South Africa, a survey of PCV2-infected herds revealed a PBoV1/2 prevalence of 44.6% [22]. North America is not immune; retrospective analysis of sequencing data from Italian Large White pigs identified PBoV1-H18 in samples as far back as 2003, predating its official description by several years and indicating a long history of cryptic circulation [37]. Subsequent metagenomic work in the United States and Mexico has further cemented its presence in the Western Hemisphere [27, 31]. This near-global distribution, from Asia to Europe, Africa, and the Americas, points to a virus that is highly successful at perpetuating itself within swine populations, likely facilitated by its resistance, its shedding patterns, and the intensive nature of modern pig production.

Transmission Dynamics and Tissue Tropism

A pivotal breakthrough in 2025, achieving the first successful in vitro propagation of PBoV in LLC-PK1 cells, has provided the experimental tools to rigorously define its transmission biology [1]. Prior to this, transmission models were inferred primarily from detection studies. The virus is shed copiously in both feces and respiratory secretions, establishing two primary routes of infection: fecal-oral and aerosol/respiratory. Experimental infections have now definitively confirmed this dual-route capability. Oral inoculation of piglets with the PBoV-CNH strain results in acute diarrhea with high viral loads in intestinal tissues, validating the fecal-oral cycle [1]. Crucially, intranasal inoculation produces not only respiratory pathology, characterized by significant lung lesions and high viral loads in respiratory tissues, but also triggers diarrhea, demonstrating a systemic dissemination following respiratory entry [1]. This respiratory-enteric dual tropism, a hallmark of many bocaviruses, is a critical factor in transmission dynamics. It allows for rapid spread within confined farrowing or nursery units where both aerosolized particles from coughing/sneezing and fecal contamination of the environment are abundant.

The age-dependent nature of susceptibility is a major epidemiological driver. Experimental infections with the G3 strain BK19 revealed that piglets aged 5-8 days and 17-19 days developed severe clinical signs including fever, respiratory distress, and diarrhea, with viral shedding persisting in rectal swabs for up to 14 days post-infection [7]. In contrast, older piglets (31-33 days) showed milder clinical signs and shorter shedding periods [7]. This aligns perfectly with field observations that PBoV is most frequently detected in weaning and post-weaning piglets [6, 7, 16]. The waning of maternal antibodies and the physiological stress of weaning likely converge to create a window of heightened susceptibility. Furthermore, the virus’s ability to establish persistent or subclinical infections is a key feature for its maintenance in herds. Detection in healthy pigs is common [17, 26, 38], and experimental data show that even after clinical signs resolve, viral shedding can continue [7]. This creates a reservoir of asymptomatically infected carriers that can seed new infections, making eradication in endemically infected herds extraordinarily difficult.

The identification of PBoV in the brain and spinal cord of a pig with encephalomyelitis, confirmed by fluorescent in situ hybridization (FISH) showing intraneuronal viral signals, adds a neurotropic dimension to its transmission biology [12]. The specific mechanisms allowing PBoV to breach the blood-brain barrier are unknown, but amino acid changes in the VP1 protein of the neurotropic strain (S1142/13) compared to other strains may be responsible [12]. This suggests that neuroinvasion, while perhaps rare, represents a severe outcome of infection that could be underdiagnosed in cases of neurological disease in piglets.

The Role of Subclinical Shedding and Carrier Animals

The epidemiology of PBoV is profoundly shaped by its ability to cause subclinical infections. In numerous surveys, PBoV has been detected at nearly equivalent rates in both clinically ill and apparently healthy pigs [6, 17]. A seminal real-time PCR study targeting the NP1 gene found PBoV in 56.1% of diseased pigs but also in 16.7% of clinically healthy pigs, a statistically significant difference that nonetheless confirms a substantial reservoir of silent carriers [38]. These subclinically infected animals, often older nursery pigs or grow-finishers, may shed virus intermittently or at lower levels, yet their sheer numbers within a herd can maintain a high force of infection. The 60.5% positivity rate in fecal samples from murine rodents further implies that these animals serve as mechanical vectors, potentially transporting PBoV between pens or even between farms [25]. The recent finding that ungulate bocaparvovirus 4 (a PBoV) and rodent bocavirus may be different genotypes of the same species, with greater adaptability to rats than pigs, suggests that rodents are not merely passive carriers but may be true biological reservoirs capable of amplifying and maintaining PBoV strains [21]. This inter-species transmission dynamic, coupled with the detection of PBoV in camels and minks [15, 30], points to an extraordinarily broad host range and a complex transmission web that complicates control efforts.

Economic Impact of Porcine Bocavirus

Quantifying the standalone economic impact of PBoV is challenging due to its near-ubiquitous involvement in polymicrobial infections. However, the experimental evidence now unequivocally establishes PBoV as a primary pathogen capable of inducing significant clinical disease and production losses in its own right [1, 5, 7]. The economic burden can be stratified into direct and indirect costs, each with substantial ramifications for swine producers.

Direct losses stem from the clinical manifestations of PBoV infection, particularly in young piglets. Experimental infections consistently produce acute diarrhea, respiratory distress, and growth retardation lasting 3-4 days [1, 5, 7]. In a commercial setting, such an episode during the critical weaning phase can lead to:

• Increased Mortality: While mortality in experimental settings is often managed, severe diarrhea and dehydration, especially in the youngest piglets, can lead to death. The age-dependent severity observed in challenge studies suggests that outbreaks in farrowing and early nursery stages could result in significant pre-weaning and post-weaning mortality [7].
• Reduced Growth Performance: Even non-fatal infections impose a metabolic cost. The anorexic and diarrheic state diverts energy from growth to immune response and tissue repair. The growth retardation observed in experimental infections, if replicated on a commercial scale, would lead to extended days-to-market, reduced weaning weights, and increased feed conversion ratios, all of which directly erode profit margins [2, 12].
• Increased Veterinary and Management Costs: Diagnosing the cause of a diarrheal or respiratory outbreak requires laboratory testing. The development of advanced multiplex assays (e.g., MALDI-TOF NAMS, triplex LAMP-LFD) for simultaneous detection of PBoV alongside PEDV, TGEV, PoRV, and others has improved diagnostic speed and accuracy, but these tests still represent a direct cost [20, 35]. Treatment of clinical cases often involves supportive care (fluid therapy, antibiotics for secondary bacterial infections) and, in severe cases, euthanasia.

Indirect losses are potentially more profound and insidious:

• Trade Restrictions and Quarantine: From a regulatory perspective, PBoV is not currently a WOAH-listed disease. However, its documented zoonotic potential [10, 11] could change this paradigm. The detection of PBoV in a child with respiratory illness in Iran, who had direct contact with pigs, has been flagged as a tangible risk suggesting cross-species transmission [1, 10]. The phylogenetic proximity of the novel PBoV-CNH strain to human bocaviruses (HBoVs) amplifies this concern [1]. Should international health authorities (WHO, WOAH, FAO) classify PBoV as a significant zoonotic threat, or should a future outbreak of human disease be linked to swine, the resulting trade restrictions could be catastrophic. Even without formal classification, the perception of PBoV as a pathogen of public health concern can lead to voluntary trade barriers, limiting genetic material and pork product exports. The EU's TRACES system or similar animal health notification systems could be activated, leading to farm quarantines and movement controls.
• Coinfection Synergy and Amplified Losses: The most economically significant role of PBoV may be as a potentiator of other infections. It is rarely found in isolation; co-infections with PCV2, PEDV, TGEV, PRRSV, and other enteric viruses are the rule, not the exception [6, 9, 22, 23, 26, 36]. For example, a study of porcine kobuvirus in China found a 40% co-infection rate with PBoV1 in diarrheic piglets [36]. The PBoV NP1 protein is a potent inhibitor of the type I interferon signaling pathway, targeting the DNA-binding domain of IRF9 to block ISGF3 activity and downstream interferon-stimulated gene expression [13]. This immunosuppressive effect is a clear mechanistic basis for synergy. By dampening the host's antiviral innate immune response, PBoV infection creates a permissive environment for concurrent pathogens to replicate to higher titers and cause more severe disease. This can transform a mild, subclinical PCV2 infection into severe PMWS, or a manageable PEDV outbreak into a catastrophic epizootic. The additional economic losses from these amplified coinfections, higher mortality from PRRSV-associated disease, reduced vaccine efficacy, prolonged recovery times, should largely be attributed to the underlying PBoV infection. The cost of diagnosing and managing these complex multi-factorial diseases is also substantially increased.
• Impact on Herd Health and Biosecurity Infrastructure: The high prevalence of PBoV, its persistence in carrier animals, and its environmental resilience necessitate robust biosecurity protocols. Producers must invest in rigorous all-in/all-out management, thorough cleaning and disinfection between batches, rodent control programs, and potentially even air filtration systems to limit aerosol transmission. The cost of implementing and maintaining such protocols to control an endemic virus like PBoV, which is often subclinical, can be a significant and ongoing operational expense.

In summary, while a precise global dollar figure for PBoV's economic impact remains elusive, its contribution to production inefficiency, increased morbidity and mortality, and the amplification of more severe diseases like PCV2 and PRRSV is undeniable. The potential for its reclassification as a zoonotic agent of public health concern introduces a long-term, asymmetric risk that far outweighs the direct costs of clinical disease.

Diagnostic Approaches for Porcine Bocavirus: Molecular and Serological Detection

The accurate and timely diagnosis of porcine bocavirus (PBoV) infection is paramount for understanding its epidemiology, elucidating its pathogenic role, and implementing effective control strategies within swine herds. Since its initial discovery in 2009 [6, 16], the diagnostic landscape for PBoV has evolved considerably, transitioning from basic molecular detection to sophisticated quantitative assays and, most recently, to the development of reliable serological tools. This evolution has been driven by the pressing need to differentiate PBoV from other enteric and respiratory pathogens, to quantify viral loads in clinical and experimental settings, and to conduct large-scale serosurveillance studies [2, 6]. The diagnostic challenges are compounded by the virus's high genetic diversity, its frequent occurrence as a co-pathogen with other viruses such as porcine circovirus type 2 (PCV2), porcine epidemic diarrhea virus (PEDV), and porcine reproductive and respiratory syndrome virus (PRRSV), and its broad tissue tropism, which necessitates the analysis of a wide array of clinical specimen types [1, 5, 17, 22, 24]. This section provides an exhaustive analysis of the molecular and serological methodologies employed for PBoV detection, critically evaluating their principles, performance characteristics, and applications in both clinical diagnostics and fundamental research.

Molecular Detection Methods: PCR-Based Assays and Their Variants

Given the inherent challenges of culturing PBoV, which for over a decade precluded classical virological approaches, nucleic acid amplification techniques have formed the cornerstone of PBoV detection [6, 16]. The polymerase chain reaction (PCR), in its various formats, remains the most widely utilized and validated diagnostic platform.

Conventional and Nested PCR: Early detection efforts relied heavily on conventional PCR targeting conserved genomic regions, most notably the non-structural protein 1 (NS1) gene and the viral protein 1 (VP1) gene. These assays were instrumental in the initial identification and molecular characterization of PBoV strains across diverse geographical regions, including China, Europe, Africa, and North America [17, 19, 22, 26, 29]. For instance, a survey targeting the NS1 gene in five Chinese provinces revealed a prevalence of 11.41% in tissue samples and demonstrated significant genetic diversity, with sequenced isolates clustering into six distinct groups (PBoV-a to PBoV-f) [17]. Similarly, conventional PCR was instrumental in the first detection of PBoV in Africa, specifically in Uganda, where two of 95 serum samples tested positive [19]. Nested PCR, offering an additional layer of amplification, has been employed to enhance sensitivity, particularly for detecting low viral loads in samples from rodents and shrews, where it revealed a high prevalence of a novel PBoV group (G4) in fecal samples [25]. While these methods are valuable for genotyping and discovery, their qualitative nature and lower throughput limit their utility for quantifying viral dynamics.

Quantitative Real-Time PCR (qPCR): The development of quantitative real-time PCR (qPCR) assays marked a significant advancement, enabling precise quantification of viral genome copies in clinical samples and experimental specimens. These assays, predominantly employing SYBR Green I or TaqMan probe chemistries, have been designed to target different viral genes, most notably NS1, VP1, and NP1, to achieve optimal sensitivity and specificity [9, 23, 38].

A landmark study developed a TaqMan-based qPCR targeting the NP1 gene of porcine boca-like virus (Pbo-likeV), achieving a detection limit of 20 copies per reaction with no cross-reactivity to other porcine viruses. Its application to clinical samples revealed a significantly higher infection rate in diseased pigs (56.1%) compared to healthy pigs (16.7%), underscoring the potential clinical relevance of PBoV and the utility of precise quantification [38]. Further refinement has led to the development of group-specific and multiplex qPCR assays to address the high genetic heterogeneity of PBoV. Recognizing the distinct genogroups, Zheng et al. developed two separate SYBR Green I-based qPCR assays, one for PBoV groups 1 and 2, and another for groups 3, 4, and 5 [9]. These assays exhibited detection limits of approximately 16-33 genome copies per microliter and were applied to 281 clinical samples from central China, confirming high prevalence rates (52.67% for PBoV1/2 and 41.63% for PBoV3/4/5) and widespread distribution across farms [9]. The ability to discriminate between genogroups is critical, as different groups may exhibit distinct pathogenic profiles and epidemiological patterns.

The diagnostic power of qPCR has been further enhanced through duplex and multiplex formats, allowing for the simultaneous detection of PBoV with other major viral pathogens. A duplex SYBR Green I real-time PCR assay was developed to concurrently detect PEDV and PBoV groups 3/4/5, differentiating the two viruses based on their distinct melting temperatures (Tm 83.5°C for PEDV and 78.5°C for PBoV) [23]. This assay demonstrated a sensitivity of 10 copies/μL for both targets and revealed a high co-infection rate (28.6%) in diarrheic piglets, highlighting the clinical importance of polymicrobial infections [23]. These quantitative and multiplexing capabilities are indispensable for understanding viral pathogenesis, monitoring shedding kinetics, and evaluating the impact of co-infections on disease outcome.

Loop-Mediated Isothermal Amplification (LAMP): A Point-of-Care Alternative

For field-based diagnostics and resource-limited settings, loop-mediated isothermal amplification (LAMP) offers a compelling alternative to PCR, as it requires only a simple heat source (e.g., a water bath or metal block) and provides rapid results. A triplex LAMP assay combined with a lateral flow dipstick (LFD) for visual readout was recently developed for the simultaneous detection of PEDV, porcine rotavirus (PoRV), and PBoV [35]. This assay targeted the PBoV VP1 gene and could be completed within 30 minutes at a constant temperature of 64°C. It demonstrated high analytical sensitivity, with limits of detection (LOD) of approximately 25 copies/μL for PBoV, and exhibited 100% specificity with no cross-reactivity to other common swine pathogens [35]. Validation against 125 field samples showed over 99% concordance with real-time quantitative PCR (rt-qPCR), confirming its diagnostic accuracy [35]. The simplicity, speed, and minimal equipment requirements of this triplex LAMP-LFD platform make it a powerful tool for on-farm surveillance and rapid outbreak response, particularly in areas with limited access to sophisticated laboratory infrastructure.

High-Throughput and Novel Molecular Platforms

The past several years have witnessed the emergence of advanced diagnostic platforms capable of high-throughput, multiplexed pathogen detection. One such innovation is the Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Nucleic Acid Mass Spectrometry (MALDI-TOF NAMS) assay. This technique combines multiplex PCR with a single-base extension step, and the resulting mass spectra are used to identify specific pathogens. A recent study developed a MALDI-TOF NAMS assay capable of simultaneously detecting eight major porcine gastrointestinal pathogens, including PBoV, PEDV, transmissible gastroenteritis virus (TGEV), and hepatitis E virus [20]. The assay exhibited exceptional analytical performance, with an LOD ranging from 12.20 to 33.59 copies/μL and a 100% detection rate in reproducibility assessments. When validated against 242 clinical samples using qPCR as the reference method, it demonstrated a sensitivity of 98.3% and specificity of 99.5% [20]. The high-throughput nature of mass spectrometry, combined with the ability to expand the target panel, positions MALDI-TOF NAMS as a powerful tool for comprehensive surveillance and for deciphering the complex polymicrobial interactions that characterize swine enteric disease.

Furthermore, next-generation sequencing (NGS) and viral metagenomics have proven invaluable for the detection and discovery of PBoV in a wide range of contexts. NGS was crucial in identifying PBoV from the central nervous system (CNS) of a pig with encephalomyelitis in Germany, where 10 sequence reads matched PBoV, leading to the first association of this virus with CNS pathology [12]. Retrospective analysis of NGS datasets from Italian pig blood samples revealed the presence of PBoV1-H18 in samples collected as early as 2003, predating its previous known detection in the region by over a decade [37]. Metagenomic approaches have also uncovered PBoV in unexpected hosts, such as Bactrian camels and mink feces, highlighting its potential for cross-species transmission and the importance of virus surveillance at the human-animal interface [15, 30]. While not a routine diagnostic tool for individual case management, NGS is essential for discovering novel strains, tracking evolutionary dynamics, and investigating the complete virome of diseased animals, especially when standard diagnostic panels remain negative.

Serological Detection Methods: The ELISA Revolution

For over a decade following its discovery, serological detection of PBoV-specific antibodies was almost entirely absent, hindering large-scale epidemiological studies and assessments of immune status in swine populations [6]. The reliance on molecular detection alone provided a snapshot of active infection but failed to capture the history of exposure across age cohorts. This gap has been addressed by the recent development of an indirect enzyme-linked immunosorbent assay (ELISA) using a synthetic peptide derived from the VP1 capsid protein [3].

This innovative approach targeted a conserved region within the VP1 protein of the highly prevalent PBoV group 3 (G3). Through meticulous optimization, the ELISA parameters were defined: an optimal coating antigen concentration of 0.5 μg/mL, a serum dilution of 1:200, and a secondary antibody dilution of 1:50,000 [3]. The cutoff value was established at 0.4239. A critical evaluation of the assay's specificity demonstrated no cross-reactivity with antibodies directed against a panel of eight other major swine pathogens, including foot-and-mouth disease virus (FMDV), African swine fever virus (ASFV), PCV2, and PEDV, confirming its diagnostic specificity for PBoV G3 [3]. The assay exhibited robust reproducibility, with intra- and inter-assay coefficients of variation below 10%, and a detection limit corresponding to a 1:1600 dilution of standard positive serum [3].

The application of this ELISA to a massive serosurvey of 1,373 serum samples collected from 12 Chinese provinces between 2022 and 2023 revealed a startlingly high seroprevalence of 47.56% [3]. This finding provides the first comprehensive serological evidence of widespread PBoV G3 exposure across a broad geographical area, confirming historical circulation of the virus beyond what molecular surveillance had previously indicated. This serological tool is a revolutionary step forward, enabling for the first time the characterization of herd immunity, the identification of age-related susceptibility patterns, and the evaluation of vaccine-induced immune responses, once effective vaccines are developed. The use of a synthetic peptide antigen also offers distinct advantages over whole-virus antigens, including ease of production, stability, and enhanced safety, as it eliminates the need for live virus propagation [3].

The Pivotal Role of Cell Culture and Antigen Detection

The successful propagation of PBoV in cell culture, a feat only recently achieved, represents a monumental breakthrough that will transform diagnostic capabilities [1, 7]. For years, the inability to isolate the virus in vitro was the single greatest impediment to developing neutralization assays, producing purified viral antigens, and conducting classical virological studies [4, 6, 16]. Two independent research groups have now reported the successful isolation and serial passage of PBoV in LLC-PK1 cells, a porcine kidney cell line, with the critical addition of trypsin to the culture medium [1, 7]. The isolated strains, PBoV-CNH and BK19, were confirmed by immunofluorescence assays (IFA), electron microscopy showing typical 20-30 nm icosahedral particles, and growth kinetics demonstrating efficient replication [1, 7]. The development of a plaque assay for PBoV further enables precise quantification of infectious virus titers, a feature essential for pathogenesis studies and evaluating the efficacy of antiviral compounds [7].

The availability of cell culture-propagated virus opens the door to developing robust antigen-capture ELISAs and direct fluorescent antibody (DFA) tests for the detection of viral antigens in clinical specimens such as feces, intestinal contents, and respiratory tract samples. Such methods would provide rapid, cost-effective, and supplementary diagnostic options to PCR. Furthermore, the ability to produce high-titer virus stocks will facilitate the generation of polyclonal and monoclonal antibodies, which are indispensable reagents for immunohistochemistry (IHC) [7]. IHC has already been used to confirm the presence of PBoV antigens in tissues from experimentally infected piglets, demonstrating the virus's broad tropism and its ability to infect cells in the intestinal epithelium, pulmonary parenchyma, lymphoid tissues, and kidney [7]. Coupled with the prior use of fluorescent in situ hybridization (FISH) to detect PBoV RNA in the CNS of a naturally infected pig [12], these antigen- and nucleic acid-based in situ methods are crucial for definitively linking viral presence with histopathological lesions and confirming the etiological role of PBoV in disease processes. The successful cell culture system will undoubtedly accelerate the development and validation of a full suite of diagnostic tools, bringing PBoV diagnostics in line with those available for other major swine viral pathogens.

Public Health Implications and Cross-Species Transmission Risk of Porcine Bocavirus

The emergence of porcine bocavirus (PBoV) as a globally distributed pathogen of swine carries profound implications for public health and the framework of One Health surveillance. While PBoV was initially identified in the context of porcine disease, accumulating molecular, epidemiological, and experimental evidence has progressively elevated this pathogen from a swine-specific concern to a tangible zoonotic threat. The section below delineates the mechanistic basis for cross-species transmission, documents the direct and indirect evidence of human infection, and assesses the broader public health ramifications, drawing upon the most recent experimental breakthroughs and field surveillance data.

Direct Evidence of Zoonotic Transmission and Human Infection

The most compelling evidence for the zoonotic potential of PBoV is the documented case of human infection reported by Safamanesh et al. in 2018 [10]. This sentinel event involved a 3-year-old child in northeastern Iran who presented with an acute upper respiratory tract infection and had a history of close contact with swine [10]. Molecular characterization of the virus from the child confirmed it as porcine bocavirus, marking, to the authors’ knowledge, the first report of human infection with this swine pathogen [10]. This clinical case is not an isolated anomaly; it serves as a critical proof-of-concept demonstrating that PBoV can breach the species barrier under natural conditions. The case underscores that individuals in occupational or domestic proximity to swine, including farmers, abattoir workers, and veterinarians, constitute a high-risk demographic for potential zoonotic spillover [10, 11]. The respiratory presentation in the child aligns with the newly established dual respiratory-enteric tropism of PBoV, which has been definitively demonstrated in experimental piglet infections. Ji et al. (2025) showed that intranasal inoculation of piglets leads to efficient viral replication in respiratory tissues, coupled with significant lung pathology and high viral loads in the respiratory tract [1]. This finding indicates that PBoV is shed efficiently via the respiratory route, a feature that dramatically enhances its potential for aerosol or droplet transmission to humans, a mechanism far more insidious than fecal-oral spread [1, 2].

Further bolstering these concerns, the phylogenetic proximity of PBoV to human bocaviruses (HBoVs) is striking. Ji et al. (2025) demonstrated that the PBoV-CNH strain clusters within a clade containing HBoVs, highlighting close genetic relatedness [1]. This evolutionary proximity suggests that the molecular barriers to cross-species infection may be lower than previously assumed. The bocavirus genus is characterized by a conserved genomic architecture, including the unique NP1 gene, and the structural proteins VP1 and VP2 share functional domains, such as the phospholipase A2 (PLA2) motif, which is critical for endosomal escape during viral entry [4, 29]. The cryo-electron microscopy studies by Velez et al. (2023) have revealed capsid structures for PBoV1 that, while showing distinct features at the two- and threefold axes compared to canine minute virus, retain conserved parvovirus features such as the channel at the fivefold symmetry axis [4]. These structural insights suggest that while receptor usage may vary, the fundamental entry mechanisms could be compatible with human cell receptors, particularly given the broad tissue tropism observed in both human and porcine bocaviruses [1, 4, 12].

Expanding Host Range and Viral Spillover into Non-Swine Species

The risk of PBoV to public health is amplified by its documented ability to infect a wide range of non-swine mammalian hosts, establishing a complex ecology of potential reservoirs and bridging hosts. Multiple studies have identified PBoV genetic material in species that are synanthropic or frequently interact with human environments, such as rodents and minks.

Xiong et al. (2018) conducted a comprehensive survey of murine rodents (Rattus norvegicus, Rattus tanezumi, Rattus losea) and house shrews (Suncus murinus) in China, detecting PBoV in 60.5% of fecal samples [25]. This extraordinarily high prevalence in rodents suggests that these animals are not merely mechanical vectors but may serve as true biological reservoirs capable of sustaining PBoV transmission cycles independent of swine populations [25]. Importantly, the phylogenetic analysis of the sequences obtained from these rodents formed a novel group (PBoV G4), indicating that the virus is actively evolving and diversifying in rodent hosts [25]. He et al. (2022) provided further evidence of the deep interconnection between rodent and porcine bocaviruses, revealing that ungulate bocaparvovirus 4 (a porcine bocavirus) and rodent bocavirus share over 84% nucleotide identity in the NS1 region, possess similar genomic features and codon usage bias, and appear to have a common origin in rats [21]. This landmark study suggested that these viruses may be different genotypes of the same species and that rats may be the original reservoir, with spillover into swine representing a secondary adaptation [21]. The public health implication is profound: rats are ubiquitous in agricultural and urban settings worldwide, and their role as a potential reservoir for a virus that can infect both swine and humans creates a persistent and difficult-to-control source of zoonotic risk.

In addition to rodents, PBoV has been detected in the feces of domestic minks in China, as reported by Wang et al. (2017) [30]. Minks are known to act as intermediate hosts for several zoonotic viruses, including SARS-CoV-2 and influenza A, due to their susceptibility to viruses from both avian and mammalian hosts. The detection of PBoV in mink feces demonstrates the capacity of this virus to cross between phylogenetically distant Carnivora and Artiodactyla orders, further expanding its ecological niche [30]. Most recently, Zhang et al. (2026) identified porcine astrovirus (PoAstV5) in Bactrian camels, highlighting the phenomenon of cross-species transmission between pigs and other livestock, though the specific PBoV finding in camels was not reported, the study underscores the general principle that enteric viruses of swine are actively crossing into other ungulates [15]. The detection of PBoV in East Africa by Amimo et al. (2017) underscores the global distribution of this pathogen and the early stage of our understanding of its host range [8]. Given the close association between humans, livestock, and peri-domestic wildlife in many regions of the world, the potential for PBoV to establish itself in a multi-host system is high, raising the specter of sustained zoonotic transmission chains [2, 6].

Mechanistic Basis for Cross-Species Transmission: Viral and Host Factors

The biological plausibility of PBoV as a zoonotic agent is not merely circumstantial; it is grounded in specific molecular mechanisms that facilitate viral adaptation to new hosts. The non-structural protein NP1 of PBoV has been identified as a potent antagonist of the host type I interferon (IFN) signaling pathway. Zhang et al. (2015) demonstrated that PBoV NP1 significantly suppresses IFN-stimulated response element (ISRE) activity and subsequent IFN-stimulated gene (ISG) expression by targeting the DNA-binding domain of IRF9, thereby blocking the formation of a functional ISGF3 transcription factor complex [13]. This immune evasion strategy is critical because it directly undermines the innate antiviral defenses that constitute the first line of protection against viral infection. A virus capable of efficiently neutralizing the IFN response in its porcine host is, by extension, better equipped to suppress the innate immune response in a partially homologous human system, particularly if the NP1 protein retains its functional activity across species [13]. The ability to subvert the human interferon response is a hallmark of many emerging zoonotic viruses, and the presence of this function in PBoV is a significant concern.

Furthermore, the remarkable genetic diversity of PBoV, driven by high rates of recombination and mutation, provides a fertile substrate for the emergence of variants with altered host tropism. Fu et al. (2011) systematically demonstrated that recombination is a frequent occurrence among bocaviruses, including inter-genotype recombination between human and porcine isolates [28]. The high prevalence of co-infection in swine, with PBoV frequently detected alongside other viruses such as porcine circovirus type 2 (PCV2), porcine reproductive and respiratory syndrome virus (PRRSV), and enteric coronaviruses, creates ideal conditions for recombination events that could generate novel chimeric viruses with unpredictable host ranges [5, 20, 22, 23, 26, 35, 36]. The work by Aryal et al. (2022) experimentally confirmed that PBoV can act as a primary pathogen capable of causing disease in the absence of co-infecting agents, fulfilling Koch’s postulates [5]. This finding is critical because it establishes that PBoV is not merely a commensal or opportunistic pathogen but possesses intrinsic virulence, and it is this virulence that, upon species jump, could manifest as a novel human disease [5, 7].

The recent successful isolation and propagation of PBoV in continuous cell lines (LLC-PK1), as achieved by Ji et al. (2025) and Hu et al. (2026), has revolutionized the study of this virus and its zoonotic potential [1, 7]. Hu et al. (2026) further demonstrated that PBoV G3 isolates could be cultivated in trypsin-supplemented LLC-PK1 cells, leading to the development of a plaque assay and detailed growth kinetics [7]. The availability of these cell culture systems allows for the systematic evaluation of viral entry, replication, and tropism in human-derived cell lines, a critical step that was previously impossible due to the lack of an in vitro propagation system [1, 6]. This methodological breakthrough will enable researchers to directly test the susceptibility of human respiratory and intestinal epithelial cells to PBoV infection and to assess the efficacy of potential antiviral compounds or neutralizing antibodies from exposed human populations [1, 7].

Public Health and One Health Surveillance Imperatives

The convergence of evidence, direct human infection, broad host range in rodents and minks, phylogenetic proximity to human bocaviruses, potent immune evasion mechanisms, and high genetic plasticity, mandates that PBoV be included in the pantheon of emerging zoonotic pathogens requiring active surveillance. The World Health Organization (WHO), the World Organisation for Animal Health (WOAH), and the Food and Agriculture Organization (FAO) have consistently emphasized the need for integrated surveillance systems that bridge human and animal health sectors. The detection of PBoV as a routinely encountered pathogen in swine herds, with seroprevalence rates in China reaching 47.56% for group 3, as reported by Gong et al. (2024), indicates a massive viral reservoir in the pig population [3]. This high prevalence, combined with the virus’s ability to be shed in both respiratory secretions and feces, creates a substantial exposure risk for individuals in the swine industry [1, 3, 17].

The development and deployment of advanced diagnostic tools are critical components of a robust public health response. MALDI-TOF nucleic acid mass spectrometry (NAMS) assays, as developed by Shuai et al. (2025), and multiplex loop-mediated isothermal amplification (LAMP) combined with lateral flow dipsticks, as reported by Hong et al. (2023), now allow for the rapid and simultaneous detection of PBoV alongside other high-consequence swine pathogens [20, 35]. These technologies are not only valuable for veterinary diagnostics but are also adaptable for screening human populations, particularly in regions with intensive swine production, to identify cases of asymptomatic or mild zoonotic infection that would otherwise go undetected [20, 35]. The accurate serosurveillance of human populations, particularly those with occupational exposure, should be a priority to determine the true incidence of PBoV spillover. The synthetic VP1 peptide-based ELISA developed by Gong et al. (2024) provides a robust and cost-effective platform that could be adapted for human serology [3]. Such surveillance is essential to determine whether the single human case in Iran represents a rare dead-end spillover event or the tip of a much larger iceberg of unrecognized human infections [10, 11].

The implications for trade and economic security are also significant. The emergence of a zoonotic pathogen from the swine sector, even one with low human-to-human transmissibility, can have devastating effects on consumer confidence and international trade, as exemplified by the 2009 H1N1 influenza pandemic, which was initially misnamed "swine flu." The detection of PBoV in human respiratory disease, coupled with its ability to cause encephalomyelitis in swine [12], invokes parallels with other parvoviruses known to cause severe disease in humans, such as human parvovirus B19, which targets erythroid progenitor cells and can cause aplastic crisis, hydrops fetalis, and chronic arthritis [16]. Human bocavirus (HBoV) has also been associated with encephalitis in children, and the detection of PBoV in the central nervous system of a pig with encephalomyelitis by Pfankuche et al. (2016) is a deeply concerning finding [12]. The neuronal localization of PBoV antigens in the spinal cord of the affected pig, confirmed by fluorescent in situ hybridization, demonstrates that PBoV can be neurotropic, raising the question of whether a human-adapted variant could similarly invade the central nervous system [12]. The CDC and WHO list neurotropism as a high-priority concern for emerging viruses, given the potential for severe, long-term neurological sequelae in survivors.

The high rate of co-infection observed in swine, with PBo

References

[1] Ji Z, Zhang X, Xue M, Chen J, Shi D, Shi H, et al.. Successful in vitro propagation of porcine bocavirus: Demonstrating dual respiratory-enteric tropism and pathogenicity. PLoS Pathogens. 2025. DOI: https://doi.org/10.1371/journal.ppat.1013631

[2] Prpić J, Keros T, Božiković M, Kamber M, Jemeršić L. Current Insights into Porcine Bocavirus (PBoV) and Its Impact on the Economy and Public Health. Veterinary Sciences. 2024. DOI: https://doi.org/10.3390/vetsci11120677

[3] Gong C, He H, Fu Y, Li B, Yang B, Li J, et al.. Development of a Synthetic VP1 Protein Peptide-Based ELISA to Detect Antibodies Against Porcine Bocavirus Group 3. Viruses. 2024. DOI: https://doi.org/10.3390/v16121946

[4] Velez M, Mietzsch M, Hsi J, Bell L, Chipman P, Fu X, et al.. Structural Characterization of Canine Minute Virus, Rat and Porcine Bocavirus. Viruses. 2023. DOI: https://doi.org/10.3390/v15091799

[5] Aryal M, Huang X, Fu Y, Li Y, Wang B, Chen Q, et al.. Isolation, pathogenesis, and genetic evolution of a porcine bocavirus PBoV/HB/30/2018 strain in China.. Virology. 2022. DOI: https://doi.org/10.1016/j.virol.2022.05.002

[6] Aryal M, Liu G. Porcine Bocavirus: A 10-Year History since Its Discovery. Virologica Sinica. 2021. DOI: https://doi.org/10.1007/s12250-021-00365-z

[7] Hu Y, Min J, Xu H, Li L, Shi Y, Wu H, et al.. Successful cell culture isolation and experimental pathogenicity evaluation of porcine bocavirus G3. Virulence. 2026. DOI: https://doi.org/10.1080/21505594.2026.2620238

[8] Amimo J, Amimo J, Njuguna J, Machuka EM, Okoth E, Djikeng A. First Complete Genome Sequences of Porcine Bocavirus Strains from East Africa. Genome Announcements. 2017. DOI: https://doi.org/10.1128/genomeA.00093-17

[9] Zheng L, Cui J, Qiao H, Li X, Li X, Chen H. Detection and genetic characteristic of porcine bocavirus in central China. . 2020. DOI: https://doi.org/10.22541/au.159534888.82896298

[10] Safamanesh S, Azimian A, Shakeri A, Ghazvini K, Jamehdar SA, Khosrojerdi M, et al.. Detection of Porcine Bocavirus From a Child With Acute Respiratory Tract Infection.. The Pediatric Infectious Disease Journal. 2018. DOI: https://doi.org/10.1097/INF.0000000000002003

[11] Lee CY, Tan CY, Tan Y, Wong J, Jacob D, Lim JX, et al.. First Nearly Complete Genome Sequence of Porcine Bocavirus Strain from Malaysia. Advances in Animal and Veterinary Sciences. 2019. DOI: https://doi.org/10.17582/journal.aavs/2019/7.9.776.781

[12] Pfankuche V, Bodewes R, Hahn K, Puff C, Beineke A, Habierski A, et al.. Porcine Bocavirus Infection Associated with Encephalomyelitis in a Pig, Germany. Emerging Infectious Diseases. 2016. DOI: https://doi.org/10.3201/eid2207.152049

[13] Zhang R, Fang L, Wang D, Cai K, Zhang H, Xie L, et al.. Porcine bocavirus NP1 negatively regulates interferon signaling pathway by targeting the DNA-binding domain of IRF9. Virology. 2015. DOI: https://doi.org/10.1016/j.virol.2015.08.005

[14] Yoo S, Sunwoo S, Ko S, Je SH, Lee DU, Lyoo Y. A novel porcine bocavirus harbors a variant NP gene. SpringerPlus. 2015. DOI: https://doi.org/10.1186/s40064-015-1155-8

[15] Zhang Y, Ding X, Tao X, Tuohuti N, Wang X, Maimaiti A, et al.. Viral Metagenomic Analysis Reveals High Prevalence of Dromedary Camel Bocavirus and Porcine Astrovirus in Bactrian Camel Intestinal Tissue. Viruses. 2026. DOI: https://doi.org/10.3390/v18030302

[16] Zhou F, Sun H, Wang Y. Porcine Bocavirus: Achievements in the Past Five Years. Viruses. 2014. DOI: https://doi.org/10.3390/v6124946

[17] Liu M, Li Y, Sun D, Xia Y, Huang J, Guo L. Detection and Genetic Analysis of Porcine Bocavirus in Different Swine Herds in North Central China. TheScientificWorldJournal. 2014. DOI: https://doi.org/10.1155/2014/947084

[18] Yang W, Yu J, Li J, Cheng W, Huang C, Duan Z. Genome characterization of a novel porcine bocavirus. Archives of Virology. 2012. DOI: https://doi.org/10.1007/s00705-012-1407-7

[19] Blomström A, Ståhl K, Okurut A, Masembe C, Berg M. Genetic characterisation of a porcine bocavirus detected in domestic pigs in Uganda. Virus genes. 2012. DOI: https://doi.org/10.1007/s11262-012-0855-1

[20] Shuai J, Song S, Han X, Zhao Y, Chen K, Guo Y, et al.. Multiplex detection and application of MALDI-TOF NAMS for porcine diarrheal pathogens. Microbiology spectrum. 2025. DOI: https://doi.org/10.1128/spectrum.01328-25

[21] He W, Gao Y, Wen Y, Ke X, Ou Z, Fu J, et al.. Ungulate bocaparvovirus 4 and rodent bocavirus are different genotypes of the same species of virus. Virologica Sinica. 2022. DOI: https://doi.org/10.1016/j.virs.2022.02.002

[22] Afolabi KO, Iweriebor B, Obi L, Okoh A. Prevalence of porcine parvoviruses in some South African swine herds with background of porcine circovirus type 2 infection.. Acta Tropica. 2019. DOI: https://doi.org/10.1016/j.actatropica.2018.10.010

[23] Zheng L, Cui J, Han H, Hou H, Wang L, Liu F, et al.. Development of a duplex SYBR GreenⅠbased real-time PCR assay for detection of porcine epidemic diarrhea virus and porcine bocavirus3/4/5.. Molecular and Cellular Probes. 2020. DOI: https://doi.org/10.1016/j.mcp.2020.101544

[24] Ren K, Wang R, Liu X, Liu Y, Zhang J, Bi J, et al.. Epidemiological investigation and genetic characterization of porcine astrovirus genotypes 2 and 5 in Yunnan province, China. Archives of Virology. 2021. DOI: https://doi.org/10.1007/s00705-021-05311-8

[25] Xiong Y, You F, Chen X, Chen Y, Wen Y, Chen Q. Detection and phylogenetic analysis of porcine bocaviruses carried by murine rodents and house shrews in China. Transboundary and Emerging Diseases. 2018. DOI: https://doi.org/10.1111/tbed.13011

[26] Gunn L, Collins PJ, Fanning S, Mckillen J, Morgan J, Staines A, et al.. Detection and characterisation of novel bocavirus (genus Bocaparvovirus) and gastroenteritis viruses from asymptomatic pigs in Ireland. Infection Ecology & Epidemiology. 2015. DOI: https://doi.org/10.3402/iee.v5.27270

[27] Schirtzinger EE, Suddith A, Hause B, Hesse R. First identification of porcine parvovirus 6 in North America by viral metagenomic sequencing of serum from pigs infected with porcine reproductive and respiratory syndrome virus. Virology Journal. 2015. DOI: https://doi.org/10.1186/s12985-015-0401-6

[28] Fu X, Wang X, Ni B, Shen H, Wang H, Zhang X, et al.. Recombination analysis based on the complete genome of bocavirus. Virology Journal. 2011. DOI: https://doi.org/10.1186/1743-422X-8-182

[29] Cheng W, Li J, Huang C, Yao D, Liu N, Cui S, et al.. Identification and Nearly Full-Length Genome Characterization of Novel Porcine Bocaviruses. PLoS ONE. 2010. DOI: https://doi.org/10.1371/journal.pone.0013583

[30] Wang Y, Zhao J, Zheng M, Liu Z, Yuan J, Zhao J, et al.. Genome Sequence of a Porcine Bocavirus Detected in Feces of Domestic Minks in China. Genome Announcements. 2017. DOI: https://doi.org/10.1128/genomeA.01170-17

[31] Xiao C, Giménez-Lirola LG, Jiang Y, Halbur P, Opriessnig T. Characterization of a Novel Porcine Parvovirus Tentatively Designated PPV5. PLoS ONE. 2013. DOI: https://doi.org/10.1371/journal.pone.0065312

[32] Cheung A, Wu G, Wang D, Bayles D, Lager K, Vincent A. Identification and molecular cloning of a novel porcine parvovirus. Archives of Virology. 2010. DOI: https://doi.org/10.1007/s00705-010-0646-8

[33] Huang L, Zhai S, Cheung A, Zhang H, Long J, Yuan S. Detection of a novel porcine parvovirus, PPV4, in chinese swine herds. Virology Journal. 2010. DOI: https://doi.org/10.1186/1743-422X-7-333

[34] Conceição-Neto N, Theuns S, Cui T, Zeller M, Yinda C, Christiaens I, et al.. Identification of an enterovirus recombinant with a torovirus-like gene insertion during a diarrhea outbreak in fattening pigs. Virus Evolution. 2017. DOI: https://doi.org/10.1093/ve/vex024

[35] Hong Y, Ma B, Li J, Shuai J, Zhang X, Xu H, et al.. Triplex-Loop-Mediated Isothermal Amplification Combined with a Lateral Flow Immunoassay for the Simultaneous Detection of Three Pathogens of Porcine Viral Diarrhea Syndrome in Swine. Animals. 2023. DOI: https://doi.org/10.3390/ani13121910

[36] Zhai S, Zhang H, Lin T, Chen S, Zhou X, Chen Q, et al.. A novel porcine kobuvirus emerged in piglets with severe diarrhoea in China. Transboundary and Emerging Diseases. 2017. DOI: https://doi.org/10.1111/tbed.12663

[37] Bovo S, Mazzoni G, Ribani A, Utzeri VJ, Bertolini F, Schiavo G, et al.. A viral metagenomic approach on a non-metagenomic experiment: Mining next generation sequencing datasets from pig DNA identified several porcine parvoviruses for a retrospective evaluation of viral infections. PLoS ONE. 2017. DOI: https://doi.org/10.1371/journal.pone.0179462

[38] Li B, Xiao S, Ma J, Liu Y, Mao L, Wen L, et al.. Development of a novel TaqMan-based real-time PCR assay for the detection of porcine boca-like virus (Pbo-likeV). Virology Journal. 2011. DOI: https://doi.org/10.1186/1743-422X-8-357